Stocks That Hit 52-Week Lows On Thursday
Stocks That Hit 52-Week Lows On Thursday
週四觸及 52 周低點的股票
On Thursday, 9 stocks made new 52-week lows.
週四,9 隻股票創下 52 周新低點。
Intriguing Points:
有趣的點數:
These stocks set new 52-week lows during the first half-hour of trading on Thursday:
這些股票在周四交易的前半小時內創下 52 周新低點:
- Varex Imaging (NASDAQ:VREX) stock achieved a new 52-week low on Thursday morning, hitting $11.28 and moving down 22.28%.
- Blue Ridge Bankshares, Inc. Common Stock (AMEX:BRBS) stock broke to a new 52-week low of $14.02 on Thursday. Shares of the company traded down 4.45%.
- Recro Pharma (NASDAQ:REPH) shares fell to $2.95 on Thursday, setting a new 52-week low with a shift of up 0.99%.
- Lantern Pharma (NASDAQ:LTRN) stock hit a yearly low of $10.51. The stock was down 3.58% for the day.
- Just Energy Group (NYSE:JE) shares hit a yearly low of $0.33. The stock was down 2.57% on the session.
- Entera Bio (NASDAQ:ENTX) stock hit a new 52-week low of $1.52. The stock was down 3.46% on the session.
- Stein Mart (NASDAQ:SMRT) stock dropped to a yearly low on Thursday of $0.15. Shares traded down 8.65%.
- Kingold Jewelry (NASDAQ:KGJI) shares hit a yearly low of $0.37. The stock was down 6.96% on the session.
- Castor Maritime (NASDAQ:CTRM) stock hit a yearly low of $0.16. The stock was down 6.41% for the day.
- 瓦雷克斯成像(納斯達克:弗雷克斯) 股市在周四早上創下 52 周新低點,觸及 11.28 美元,跌幅為 22.28%。
- 藍嶺銀行股份有限公司普通股(AMEX:BRBS) 股票週四突破 52 周新低點 14.02 美元。該公司股價下跌了 4.45%。
- 雷克羅製藥(納斯達克:清新表) 週四股價跌至 2.95 美元,創下 52 周新低,上漲 0.99%。
- 燈籠製藥(納斯達克:LTRN) 股票觸及年度低點 10.51 美元。當天庫存下跌了 3.58%。
- 只是能源集團(紐約證券交易所:流行) 股票觸及每年低點 0.33 美元。在會議上,庫存下降了 2.57%。
- 實業生物(納斯達克:ENTX) 股票創下 52 周新低點 1.52 美元。在會議上,庫存下降了 3.46%。
- 斯坦瑪特(納斯達克:衝擊) 週四股票跌至每年低點 0.15 美元。股票交易下跌 8.65%。
- 金高珠寶(納斯達克:千克力) 股票觸及每年低點 0.37 美元。在會議上,庫存下降了 6.96%。
- 卡斯特海事(納斯達克:CTRM) 股票觸及每年低點 0.16 美元。當天庫存下跌了 6.41%。
As other companies hit new 52-week lows, Benzinga will keep traders updated. Stay with us for further analysis on these and other companies.
隨著其他公司創下 52 周新低點,Beninga 將使交易者保持最新情況。留在我們這些公司和其他公司的進一步分析。
譯文內容由第三人軟體翻譯。
以上內容僅用作資訊或教育之目的,不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。